The three main objectives of the proposed studies on assembly of CNS myelin are (1) characterization of the role of lipids in intracellular transport of myelin components, (2) characterization of the processing of myelin proteins between their synthesis and assembly into myelin, with emphasis on extra-myelin pools of proteolipid protein, and (3) further development of methods for isolation of Golgi-enriched fractions, and characterization of the role of the Golgi apparatus in processing of lipids and proteins destined for myelin. These studies are designed to increase our understanding of membrane biogenesis, and more specifically myelination, a major event in maturation of the nervous system. Brain slices from young rats will be used to examine the effects of various agents on transport of galactolipids, phospholipids, cholesterol and gangliosides to myelin. Agents to be studied include the Golgi-disrupting compounts monensin and Co++; the microtubule-binding agents colchicine and taxol; fenfluramine and propanolol, inhibitors of the synthesis of choline and ethanolamine phospholipids; and 20, 25 diazocholesterol, and inhibitor of cholesterol synthesis. The metabolism of extra-myelin pools of proteolipid protein will be examined with regard to long-term turnover, and accumulation in the presence of monensin. Effects of taxol and Co++ on transport of myelin proteins will be characterized. Golgi-enriched fractions will be further characterized and examined using immunoblot methodology and metabolic studies to determine whether myelin proteins are processed through Golgi membranes. Finally the possible role of proton gradients in intracellular transport of proteolipid protein will be examined by comparing the effects of monensin to the effects of chloroquine, a weak base which can raise intravesicular pH, and of selected ionophores such as nigericin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS013143-08A1
Application #
3395110
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1977-04-01
Project End
1987-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
8
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
Schools of Medicine
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Benjamins, Joyce A; Nedelkoska, Liljana (2007) Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury. Neurochem Res 32:321-9
Boullerne, Anne I; Benjamins, Joyce A (2006) Nitric oxide synthase expression and nitric oxide toxicity in oligodendrocytes. Antioxid Redox Signal 8:967-80
Studzinski, Diane M; Benjamins, Joyce A (2005) Expression of P0 glycoprotein in CNS glia: effects of overexpression in N20.1 cells. Glia 52:234-44
Benjamins, Joyce A; Nedelkoska, Liljana; George, Edwin B (2003) Protection of mature oligodendrocytes by inhibitors of caspases and calpains. Neurochem Res 28:143-52
Studzinski, Diane M; Benjamins, Joyce A (2003) Regulation of CNS glial phenotypes in N20.1 cells. J Neurosci Res 73:31-41
Studzinski, D M; Benjamins, J A (2001) Cyclic AMP differentiation of the oligodendroglial cell line N20.1 switches staurosporine-induced cell death from necrosis to apoptosis. J Neurosci Res 66:691-7
Boullerne, A I; Nedelkoska, L; Benjamins, J A (2001) Role of calcium in nitric oxide-induced cytotoxicity: EGTA protects mouse oligodendrocytes. J Neurosci Res 63:124-35
Studzinski, D M; Callahan, R E; Benjamins, J A (1999) Increased intracellular calcium alters myelin gene expression in the N20.1 oligodendroglial cell line. J Neurosci Res 57:633-42
Boullerne, A I; Nedelkoska, L; Benjamins, J A (1999) Synergism of nitric oxide and iron in killing the transformed murine oligodendrocyte cell line N20.1. J Neurochem 72:1050-60
Studzinski, D M; Ramaswamy, R; Benjamins, J A (1998) Effects of cyclic AMP on expression of myelin genes in the N20.1 oligodendroglial cell line. Neurochem Res 23:435-41

Showing the most recent 10 out of 25 publications